bims-mitran Biomed News
on Mitochondrial translation
Issue of 2026–11–08
two papers selected by
Andreas Kohler, Umeå University



  1. Genet Mol Biol. 2026 ;pii: S1415-47572026000500131. [Epub ahead of print]49Suppl 1(Suppl 1): e20260020
      Mitochondria are essential organelles in mammalian cells, performing multiple functions ranging from energy metabolism and intracellular signaling to the regulation of cell fate. Proper mitochondrial function depends on the coordinated expression of two distinct genomes: the nuclear genome and the mitochondrial genome, known as mitochondrial DNA (mtDNA). Although most mitochondrial proteins are encoded by nuclear genes, mtDNA encodes 13 polypeptides that are essential components of the oxidative phosphorylation (OXPHOS) system and ATP production. For reasons that are not yet fully understood, mtDNA accumulates DNA damage at levels estimated to be 1-5 times higher than those observed in nuclear DNA, underscoring the importance of efficient DNA repair and damage tolerance mechanisms within mitochondria. Mammalian mitochondria are competent in several DNA repair pathways, with base excision repair being the best characterized. However, the molecular mechanisms underlying DNA damage response (DDR) pathways activated by mtDNA lesions remain poorly defined. In this review, we briefly summarize the established DNA repair pathways operating in mammalian mitochondria, which have been extensively discussed elsewhere, and focus primarily on DDR components implicated in the response to mtDNA damage, as well as on the cellular consequences of mtDNA damage accumulation.
    DOI:  https://doi.org/10.1590/1678-4685-GMB-2026-0020
  2. Acta Biochim Biophys Sin (Shanghai). 2026 Nov 06.
      Mitochondrial DNA (mtDNA) mutations constitute major genetic determinants of mitochondrial disorders and contribute to the progressive dysfunction of energy-demanding tissues. However, precise manipulation of the mitochondrial genome remains a formidable challenge for decades due to the unique structural and biological features of mitochondria. Recent breakthroughs in mitochondrial base-editing technologies address longstanding barriers in mitochondrial genome engineering by enabling programmable nucleotide conversion without introducing DNA double-strand breaks. Mitochondrial base editing evolves rapidly from a proof-of-concept strategy in cultured cells into a versatile platform for generating animal models, dissecting mitochondrial gene function and exploring therapeutic interventions for mitochondrial diseases. Recent advances enable the creation of animals carrying defined pathogenic mtDNA variants and provide initial evidence supporting the feasibility of in vivo mitochondrial genome correction and disease amelioration. Here, we review the evolution of mitochondrial base-editing technologies and summarize the major editing platforms, with particular emphasis on recent advances in editor engineering, expansion of targeting capabilities, generation of animal disease models and emerging therapeutic applications. We further discuss the remaining challenges, including editing precision, target-site accessibility, delivery efficiency, and comprehensive safety evaluation. Finally, we highlight future opportunities for developing next-generation mitochondrial genome-editing systems and advancing their translation toward clinical applications.
    Keywords:  base editing; gene editing; mitochondrial disease
    DOI:  https://doi.org/10.3724/abbs.2026192